An elevated concentration of serum double negative α/β T cells comprising more than 1.5% of the total lymphocytes or at least 2.5% of total T cells along with chronic lymphadenopathy or splenomegaly for more than 6 months are the two required testing for clinical diagnosis of Autoimmune lymphoproliferative<unk>  which leads to ancillary testing. Confirmatory testing for ALPS is the testing for the ALPS-related mutations or functional testing of patient T cells are requires according to the 2010 guidelines.
Autoimmune lymphoproliferative syndrome laboratory findings
Mast cell leukemia laboratory findings
Autoimmune lymphoproliferative syndrome physical examination
Mast cell tumor laboratory findings
Hodgkin's lymphoma laboratory findings
Myeloproliferative neoplasm laboratory findings
HIV Immune Complex Kidney Disease laboratory findings
Autoimmune polyendocrine syndrome laboratory findings